<HTML>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2020 [PPXV9M0ULJ50VJGHF9CJ]. www.edgarsuite.com -->
<HEAD>
<TITLE>Current Event Report - Form 8-K</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><P align=center style='font:12pt Times New Roman;line-height:12pt;margin:0'><FONT style=line-height:12pt><B>UNITED STATES</B></FONT><BR><FONT style=line-height:12pt><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR><FONT style=line-height:12pt><B>Washington, D.C. 20549</B></FONT></P>
<P align=justify style='font:11pt Times New Roman;line-height:12pt;margin:0'>&nbsp;</P>
<P align=center style='font:14pt Times New Roman;line-height:12pt;margin:0'><A name=_DV_M1 /><FONT style='border-bottom:1px solid #000000;line-height:12pt'><B>FORM 8-K/A</B></FONT></P>
<P align=justify style='font:11pt Times New Roman;line-height:12pt;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;line-height:12pt;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;line-height:12pt;margin:0'><A name=_DV_M2 /><FONT style=line-height:12pt>CURRENT REPORT</FONT></P>
<P align=center style='font:10pt Times New Roman;line-height:12pt;margin:0'><FONT style=line-height:12pt>PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></P>
<P align=justify style='font:10pt Times New Roman;line-height:12pt;margin:0'><A name=_DV_M3 /><BR><FONT style=line-height:12pt>Date of Report &nbsp;(Date of earliest event reported): March 31, 2014 &nbsp;&nbsp;</FONT></P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:14pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>Agra Nutraceuticals Corporation</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_DV_M4 /><A name=_DV_M5 /> (Exact name of registrant as specified in its charter)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:172.65pt;padding-left:7.2pt;padding-right:7.2pt><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'>Colorado</FONT></P>
</TD><TD valign=top style=width:113.9pt;padding-left:7.2pt;padding-right:7.2pt><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'>033-17966-LA</FONT></P>
</TD><TD valign=top style=width:138.4pt;padding-left:7.2pt;padding-right:7.2pt><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'>94-3030021</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:172.65pt;padding-left:7.2pt;padding-right:7.2pt><P align=center style='font:9pt Times New Roman;margin:0'>(State or other jurisdiction of incorporation)</P>
</TD><TD valign=top style=width:113.9pt;padding-left:7.2pt;padding-right:7.2pt><P align=center style='font:9pt Times New Roman;margin:0'>(Commission File Number)</P>
</TD><TD valign=top style=width:138.4pt;padding-left:7.2pt;padding-right:7.2pt><P align=center style='font:9pt Times New Roman;margin:0'>(IRS&#160;Employer<BR>Identification&#160;No.)</P>
</TD></TR>
</TABLE>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'>67 SW 12th Ave, Ste 500, Deerfield Beach, Florida USA 33442</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Address of Principal Executive Offices)</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>(954) 324-3449 </FONT><BR>(Registrant&#8217;s telephone number, including area code)</P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:307.1pt><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>International Wood Corporation</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'>155 W.&#160;Washington Blvd. # 1005&#160;Los Angeles, CA 90015</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:307.1pt><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>(Former name or former address, if changed since last report)</FONT></P>
</TD></TR>
</TABLE>
<P align=justify style='font:11pt Times New Roman;line-height:12pt;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;line-height:12pt;margin:0'><A name=_DV_M6 /><FONT style=line-height:12pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;line-height:12pt;margin:0'><A name=_DV_M8 /><FONT style=line-height:12pt>Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</FONT></P>
<P style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#211D1E'><FONT face=Wingdings>&#112;</FONT> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P>
<P style='font:10pt Times New Roman;margin:0;color:#211D1E'><FONT face=Wingdings>&#112;</FONT> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P>
<P style='font:10pt Times New Roman;margin:0;color:#211D1E'><FONT face=Wingdings>&#112;</FONT> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </P>
<P style='font:10pt Times New Roman;margin:0;color:#211D1E'><FONT face=Wingdings>&#112;</FONT> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </P>
<P style='font:10pt Times New Roman;margin-top:10pt;margin-bottom:10.5pt;color:#211D1E'>Securities registered pursuant to Section 12(b) of the Act: &nbsp;N/A</P>
<TABLE align=center style='border-collapse:collapse;border:0.5pt solid #000000'><TR><TD valign=top style='width:155.8pt;padding-left:5.4pt;padding-right:5.4pt;border:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt;color:#211D1E>Title of each class</FONT></P>
</TD><TD valign=top style='width:155.85pt;padding-left:5.4pt;padding-right:5.4pt;border:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0;color:#211D1E'>Trading </P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt;color:#211D1E>Symbol(s)</FONT></P>
</TD><TD valign=top style='width:155.85pt;padding-left:5.4pt;padding-right:5.4pt;border:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt;color:#211D1E>Name of each exchange on which registered</FONT></P>
</TD></TR>
<TR><TD valign=top style='width:155.8pt;padding-left:5.4pt;padding-right:5.4pt;border:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=top style='width:155.85pt;padding-left:5.4pt;padding-right:5.4pt;border:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=top style='width:155.85pt;padding-left:5.4pt;padding-right:5.4pt;border:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:10.35pt;margin-right:16.5pt;color:#211D1E'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </P>
<P align=right style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:10.35pt;color:#211D1E'>Emerging growth company &#160;&#160;&#160;&#160;&#160;<FONT face=Wingdings>&#112;</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:5.15pt;color:#211D1E'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;&#160;<FONT face=Wingdings>&#112;</FONT></P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Item 2.02 Attached as Exhibits are audited financial statements for periods ending December 31 2011 and December 31, 2012.</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Agra Neutraceuticals (the &quot;Company&quot;) is amending Item 2.01 of its 8-K filed on April 18, 2014, deleting the disclosure in this item in its entirety.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;color:#211D1E'><FONT style=color:#000000><B>Item 5.01</B> </FONT><B>Changes in Control of Registrant.</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;color:#211D1E'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><A name=_Hlk33426679 />Agra Nutraceuticals (the &#8220;Company&#8221;) is amending Item 5.01 of its 8-K filed on April 18, 2014, deleting the disclosure in this item in its entirety<A name=_Hlk33426303 />.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;color:#211D1E'><B>Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;color:#211D1E'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The Company is amending Item 5.02 as David Lilly was a director of the Company since its inception and Mr. Sassoon resigned as an Officer and Director on August 1, 2008 and has not been re-elected or appointed an Officer or Director of the Company. &nbsp; Mr. Sassoon was president of the Company&#8217;s subsidiary, Norwest SA.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Item 9.01 Audited financial statements of Registrant for the&#160;years 2011 and 2012 follow.</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>&#160;</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Agra Nutraceuticals (the &#8220;Company&#8221;) is amending Item 9.01 of its 8-K filed on April 18, 2014, deleting the disclosure in this item in its entirety. The financial statements were filed in the 8K dated April 18, 2-4 were not reviewed by a PCAOB Auditor and were filed accidently.</FONT></P>
<P align=justify style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin-top:5pt;margin-bottom:5pt;color:#000000'><B>SIGNATURES</B></P>
<P align=justify style='font:10pt Times New Roman;line-height:12pt;margin:0;color:#000000'><A name=_DV_M37 /><FONT style=line-height:12pt>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P align=justify style='font:10pt Times New Roman;line-height:12pt;margin:0;color:#000000'>&nbsp;</P>
<P style='font:10pt Courier New;line-height:12pt;margin:0;margin-left:10.8pt;color:#000000'><KBD style=margin-left:207pt></KBD><FONT style='font-family:Times New Roman;line-height:12pt'><B>Agra Nutraceuticals Corporation </B></FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;line-height:12pt;margin:0;color:#000000'><FONT style=line-height:12pt><B>DATE: March 2, 2020</B></FONT></P>
<P style='font:10pt Times New Roman;line-height:12pt;margin:0;color:#000000'>&nbsp;</P>
<P style='font:10pt Times New Roman;line-height:12pt;margin:0;margin-left:216pt;color:#000000'><FONT style='border-bottom:1px solid #000000;line-height:12pt'> &nbsp;&nbsp;/s/David Lilly</FONT><FONT style=line-height:12pt>________________</FONT></P>
<P style='font:10pt Times New Roman;line-height:12pt;margin:0;margin-left:216pt;color:#000000'><FONT style=line-height:12pt><B>Name: &nbsp;David Lilly </B></FONT></P>
<P style='font:10pt Times New Roman;line-height:12pt;margin:0;margin-left:216pt;color:#000000'><FONT style=line-height:12pt><B>Title: Director, Secretary</B></FONT></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "an_8k.htm", "description": "CURRENT EVENT REPORT - FORM 8-K", "secsgml_size_bytes": 13592}]
{"company-data": {"conformed-name": "Agra Nutraceuticals Corp", "cik": "0000824430", "assigned-sic": "0800", "irs-number": "943030021", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "033-17966-LA", "film-number": "20685962"}, "business-address": {"street1": "67 S.W. 12TH. AVE,, STE. #500", "city": "DEERFIELD BEACH", "state": "FL", "zip": "33442", "phone": "(888) 996-0712"}, "mail-address": {"street1": "67 S.W. 12TH. AVE,, STE. #500", "city": "DEERFIELD BEACH", "state": "FL", "zip": "33442"}, "former-company": [{"former-conformed-name": "INTERNATIONAL WOOD CORP", "date-changed": "19980206"}, {"former-conformed-name": "XANTHIC ENTERPRISES INC", "date-changed": "19970319"}]}
Current Event Report - Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report  (Date of earliest event reported): March 31, 2014
Agra Nutraceuticals Corporation
(Exact name of registrant as specified in its charter)
Colorado
033-17966-LA
94-3030021
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
67 SW 12th Ave, Ste 500, Deerfield Beach, Florida USA 33442
(Address of Principal Executive Offices)
(954) 324-3449
(Registrant's telephone number, including area code)
International Wood Corporation
155 W. Washington Blvd. # 1005 Los Angeles, CA 90015
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
p
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
p
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
p
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
p
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:  N/A
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
p
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
p
Item 2.02 Attached as Exhibits are audited financial statements for periods ending December 31 2011 and December 31, 2012.
Agra Neutraceuticals (the "Company") is amending Item 2.01 of its 8-K filed on April 18, 2014, deleting the disclosure in this item in its entirety.
Item 5.01
Changes in Control of Registrant.
Agra Nutraceuticals (the "Company") is amending Item 5.01 of its 8-K filed on April 18, 2014, deleting the disclosure in this item in its entirety
.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
The Company is amending Item 5.02 as David Lilly was a director of the Company since its inception and Mr. Sassoon resigned as an Officer and Director on August 1, 2008 and has not been re-elected or appointed an Officer or Director of the Company.   Mr. Sassoon was president of the Company's subsidiary, Norwest SA.
Item 9.01 Audited financial statements of Registrant for the years 2011 and 2012 follow.
Agra Nutraceuticals (the "Company") is amending Item 9.01 of its 8-K filed on April 18, 2014, deleting the disclosure in this item in its entirety. The financial statements were filed in the 8K dated April 18, 2-4 were not reviewed by a PCAOB Auditor and were filed accidently.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Agra Nutraceuticals Corporation
DATE: March 2, 2020
/s/David Lilly
________________
Name:  David Lilly
Title: Director, Secretary